Elanco to divest brands, forgo Canadian rights for Bayer's unit deal
Reuters
Published Jul 14, 2020 03:46PM ET
(Reuters) - Elanco Animal Health Inc (N:ELAN) has decided against acquiring Bayer AG 's Canadian distribution rights to several poultry insecticides, Canada's Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal.
The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer (OTC:BAYRY)'s feline dewormer Profender to address competition concerns about its acquisition of the German firm's veterinary drugs unit.
The Competition Bureau said Elanco and Bayer's (DE:BAYGn) animal health unit were each other's closest rivals in several Canadian markets and a potential combination would result in a substantial decrease in competition.
It added that Elanco could not buy Bayer's other poultry insecticides with darkling beetle coverage for 10 years and significant interest in any such product for two years without providing an advance notice to the Bureau.
Bayer's CropScience unit has the Canadian distribution rights to its poultry insecticides Tempo, Credo, QuickBayt and Annihilator Polyzone.
Elanco last month secured European Union antitrust clearance to buy Bayer's veterinary drugs unit after pledging to sell some products to address competition concerns regarding the deal.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.